EDGAR Filing Documents for 0001193125-11-063548

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-11-063548

Filing Date

2011-03-11

Accepted

2011-03-11 13:17:14

Documents

Period of Report

2010-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	1180878
2	AMENDED AND RESTATED LICENSE AGREEMENT	dex1027.htm	EX-10.27	109921
3	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	dex231.htm	EX-23.1	2363
4	CERTIFICATION OF CHIEF EXECUTIVE OFFICER	dex311.htm	EX-31.1	8470
5	CERTIFICATION OF CHIEF FINANCIAL OFFICER	dex312.htm	EX-31.2	8463
6	CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER	dex321.htm	EX-32.1	8424
7	GRAPHIC	g152162g49h97.jpg	GRAPHIC	44841
	Complete submission text file	0001193125-11-063548.txt		1381482

Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037

Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600

Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)